EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monoclonal Antibody Dispensing Around Pregnancy: A Descriptive Analysis Using Electronic Health Records in Italy

Elisabeth Aiton iD, Valeria Nazzari, Rosie Cornish iD, Benjamin G Faber iD, Christy Burden, Katherine Birchenall, Maria Carolina Borges iD, Deborah A Lawlor, Luisa Zuccolo iD

Pharmacoepidemiology and Drug Safety · 2026-11 · 35 (11)

DOI: 10.1002/pds.70518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 05.11.2026. Verfasst von Elisabeth Aiton und 8 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Autoimmune Diseases, Pregnancy Complications, Electronic Health Records. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe trends in dispensing of monoclonal antibody biologics (mAbs) for autoimmune conditions during and around pregnancy.

Methods

We conducted a population‐wide study of women of reproductive age (14–49 years) resident in Lombardy, Italy, between 2012 and 2024. We described trends over time in the prevalence of mAb dispensations among women of reproductive age, and during pregnancy. For each pregnancy, we assessed the prevalence of mAb dispensations before, during, and after pregnancy in trimesters. We described dispensing patterns and explored maternal factors associated with discontinuation.

Results

We included 1 871 929 women of reproductive age and 855 865 pregnancies. Prevalence of mAb dispensing during pregnancy increased over 60‐fold over the study period, from 0.0041% in 2012 to 0.27% in 2024. Pregnancy affected mAb dispensing, with prevalence decreasing from 0.081% before pregnancy to 0.051% by the third trimester. Over half ( n = 385/722, 53.3%) of pre‐existing mAb users discontinued before or during pregnancy, while switching between mAbs during pregnancy was rare ( n = 24/722, 3.3%). Discontinuation decreased over time, and varied substantially between mAbs. We found limited evidence that sociodemographic factors were associated with discontinuation, but that some health factors may be, such as use of assisted reproductive technology (OR = 1.92, 95% CI: 0.98–3.77).

Conclusions

Italian population‐wide data from 2012 to 2024 show an increase in mAbs dispensed during pregnancy, and fewer instances of discontinuing these drugs over time. These trends may reflect increasing drug availability, accumulating safety evidence, and recent changes in guidelines for mAb use in pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAutoimmune DiseasesPregnancy ComplicationsElectronic Health RecordsFemaleItalyHumansPregnancyAdultAdolescentYoung AdultMiddle Aged

Stichwörter der Autor:innen

autoimmunebiologicsdescriptivedispensingmonoclonal antibodypregnancyreal‐world evidence

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Health Data Science Centre, Human Technopole, Milan, Italy.
  • MOX, Department of Mathematics, Politecnico di Milano, Milan, Italy.
  • Musculoskeletal Research Unit, University of Bristol, Bristol, UK.
  • Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

ORCID-Profile: Elisabeth Aiton, Rosie Cornish, Benjamin G Faber, Maria Carolina Borges, Luisa Zuccolo

Förderung

  • Medical Research Council
  • Wellcome Trust
  • British Heart Foundation
  • European Union's Horizon Europe Research and Innovation Programme
  • Horizon Europe Project STAGE
  • Leducq Foundation
  • Fondation Leducq

Zitieren

APA

Aiton, E., Nazzari, V., Cornish, R., Faber, B. G., Burden, C., Birchenall, K., Borges, M. C., Lawlor, D. A., & Zuccolo, L. (2026). Monoclonal Antibody Dispensing Around Pregnancy: A Descriptive Analysis Using Electronic Health Records in Italy. Pharmacoepidemiology and Drug Safety, 35(11). https://doi.org/10.1002/pds.70518

Vancouver

Aiton E, Nazzari V, Cornish R, Faber BG, Burden C, Birchenall K, et al. Monoclonal Antibody Dispensing Around Pregnancy: A Descriptive Analysis Using Electronic Health Records in Italy. Pharmacoepidemiology and Drug Safety. 2026;35(11). doi:10.1002/pds.70518

BibTeX
@article{Aiton2026,
  author = {Aiton, Elisabeth and Nazzari, Valeria and Cornish, Rosie and Faber, Benjamin G and Burden, Christy and Birchenall, Katherine and Borges, Maria Carolina and Lawlor, Deborah A and Zuccolo, Luisa},
  title = {Monoclonal Antibody Dispensing Around Pregnancy: A Descriptive Analysis Using Electronic Health Records in Italy},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {11},
  doi = {10.1002/pds.70518}
}
Kostenlos starten →